Eligible females aged nine to 26 in Singapore will receive subsidised access to the Gardasil 9 human papillomavirus vaccine starting Jan 1, 2027, according to a joint statement by the Ministry of Health, Health Promotion Board, and Communicable Diseases Agency. The HPV9 vaccine, which covers roughly 90 per cent of cervical cancers compared to about 70 per cent for the HPV2 vaccine, will be added to the National Childhood Immunisation Schedule, the National Adult Immunisation Schedule, and the Subsidised Vaccine List.
Subsidies and MediSave usage for Gardasil 9
Under the policy change taking effect on Jan 1, 2027, government subsidies and MediSave usage will extend to the Gardasil 9 vaccine for eligible Singaporeans and permanent residents. Eligible Singaporean children will receive full subsidies at CHAS GP clinics and polyclinics. Eligible Singaporean adults qualify for means-tested subsidies of up to 75 per cent at these clinics, while eligible permanent residents can receive subsidies at polyclinics. MediSave can also be used under the prevailing Chronic and Preventive Care withdrawal limits, though subsidies and MediSave will not apply to additional doses for individuals who have already finished their recommended series.
School Immunisation Program Transition to Gardasil 9
Secondary 1 and 2 female students in Singapore will receive the Gardasil 9 vaccine in schools in place of the HPV2 vaccine, known as Cervarix, starting Jan 1, 2027. Female students who received HPV2 as their first dose in 2026 will complete their series in schools in 2027 with HPV9 as their second dose. Vaccinations provided through the Health Promotion Board school-based immunisation programme remain free of charge for eligible students.
Expert committee sets dosing schedules and compares coverage
The Expert Committee on Immunisation updated its recommendations alongside the vaccine addition, setting a two-dose schedule for individuals receiving their first dose between ages nine and 14, and a three-dose schedule for those starting between ages 15 and 26. If vaccination is started but not completed by age 26, the remaining doses can be taken after age 26 up to age 45. While both HPV2 and HPV9 protect against HPV types 16 and 18—responsible for 70 per cent of cervical cancers—HPV9 covers additional strains accounting for another 20 per cent. Cervarix remains on both schedules as an alternative choice outside of schools, whereas the Gardasil 4 vaccine is no longer available in Singapore.
Booking Procedures and Pricing Details
Patients can book vaccination appointments at participating CHAS GP clinics through the national booking portal at vaccine.gov.sg or make appointments at polyclinics, with Healthier SG enrollees encouraged to visit their enrolled clinic. Without government subsidies, private providers such as Singapore Women’s Clinic currently charge S$250 per dose for HPV9, compared to S$96 for HPV2. Women aged 27 or above who have not yet started vaccination are not eligible for subsidies or MediSave use because the vaccine is not recommended under the adult schedule for that age bracket, though they may still get vaccinated privately.
Who is eligible for HPV9 vaccine subsidies
Who is eligible for subsidies on the HPV9 vaccine starting in 2027?
Eligible Singaporean children will receive full subsidies at CHAS GP clinics and polyclinics, while eligible Singaporean adults can receive means-tested subsidies of up to 75 per cent. Eligible permanent residents can access subsidies at polyclinics, and Secondary 1 and 2 female students receive the vaccine at no charge through the school-based immunisation programme.
What happens to students who already started with HPV2?
Female students who received the HPV2 vaccine as their first dose in 2026 will complete their series in schools in 2027 by receiving the HPV9 vaccine as their second dose.
How many doses are required under the updated guidelines?
Individuals receiving their first dose between the ages of nine and 14 require two doses, while those starting between ages 15 and 26 require three doses, as recommended by the Expert Committee on Immunisation.
Can MediSave be used to pay for Gardasil 9?
Yes, MediSave use will be extended to HPV9 for recommended groups under the National Childhood Immunisation Schedule and National Adult Immunisation Schedule, subject to prevailing Chronic and Preventive Care withdrawal limits.